<DOC>
	<DOC>NCT01761682</DOC>
	<brief_summary>The investigators would like to propose a prospective longitudinal observational cohort study for patients who will be diagnosed and/or treated for acute lymphoblastic leukemia at Asan Medical Center, Seoul, Korea, to use the acquired data for fundamentals of other retrospective analysis.</brief_summary>
	<brief_title>Acute Lymphoblastic Leukemia Registry at Asan Medical Center</brief_title>
	<detailed_description>1. Acquisition of informed concent form 2. Data acquisition from medical record including - demographic / disease-associated factors - details of treatment, and its results - complications during treatment - genetic data - survival outcome (upto 10 years) 3. Accumulation of data for 30 years 4. Use of data for other retrospective analysis (including Asan Medical center Cell Banking basic data)</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia, Lymphoid</mesh_term>
	<mesh_term>Precursor B-Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia, Biphenotypic, Acute</mesh_term>
	<criteria>All patients who are diagnosed and/or treated as acute lymphoblastic leukemia at Asan Medical Center (including biphenotypic acute leukemia with Philadelphilapositive, Burkitt leukemia/lymphoma) 15 years of age and over All patients who give written consent according to guidelines at Asan Medical Center committee on human research Patients who refuse to give consent to registering</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>